Her medical history was significant for pyelonephritis, pneumonia, hepatitis A infection, hepatitis B infection, and Epstein-Barr virus exposure. Her current medications included prednisone (50 mg administered orally four times a day), aminocaproic acid (Amikar; 1 g administered four times a day, every 6 h), and cyclosporine (200 mg administered orally four times a day).
walls; numerous oidia in chains; extremely low colonies; and restricted growth at 36°C. This paper describes the isolate and strives to alert the clinical microbiologist to this rarely reported pathogen.
Zygomycosis is an umbrella term encompassing all mycotic diseases caused by fungi in the class Zygomycetes. Some prefer the term mucormycosis, because most of the fungi pathogenic to humans are found in the order Mucorales and produce a distinctive disease in the debilitated patient (4) . Risk factors include diabetic ketoacidosis, neutropenia, immunosuppressive therapy, severe trauma, protein-calorie malnutrition, and iron overload with or without deferoxamine (4, 5, 9) . Clinical manifestations include rhinocerebral, pulmonary, cutaneous, gastrointestinal, central nervous system, disseminated, and miscellaneous disorders (9) . The most frequently encountered etiologic agent for humans is Rhizopus oryzae (arrhizus) (4) . Species of Mucor are rarely agents of zygomycosis (5, 6 During hospitalization, the patient developed a well-circumscribed lesion of the thigh, which was evaluated as described below. The patient was treated with amphotericin B (Fungizone), responded favorably, and was discharged.
Laboratory studies. The thigh lesion was biopsied and the specimen was sent to the dermatopathology laboratory. The hematoxylin-and-eosin-stained preparation revealed broad, nonseptate, nonbranching hyphal fragments in the dermis compatible in morphology with a Zygomycete. Two swabs were taken from the biopsy site at different times on the same day and sent to the mycology laboratory for culture to rule out aspergillosis. The swabs were streaked onto homemade Sabouraud dextrose agar (SDA) plus 0.1% yeast extract, Mycosel (BBL Microbiology Systems, Cockeysville, Md.), and brain heart infusion agar (BBL). Direct examination of the swabs by using 10% NaOH plus glycerol showed them to be negative for fungi. (Fig. 1) . Cultures showed optimal growth at 30°C, restricted growth at 36°C, and no growth at 40°C or above. Sporangiophores arose directly from the substrate mycelium and were up to 14 p.m in diameter, hyaline, smooth to slightly roughened, short, and erect. Branching of the sporangiophores was sympodial (Fig. 2) (Fig.  3) . Sporangial walls were frequently persistent, and sporangia were often observed intact. Columellae (14 to 28 p.m long by 14 to 22 p.m wide) were smooth, hyaline, applanate, subglobose, conical, and cylindrical and frequently had collars (Fig. 4) . Sporangiospores (4 to 8 p.m in diameter) were ovoid to globose, smooth, hyaline, thin walled, and homogeneous. Qidia (4 to 14 p.m in diameter) were numerous and hyaline and were observed in terminal or intercalary chains. They were globose to elongate and thin walled when young and thick walled with a dense cytoplasm when mature. Our biochemical test results indicated that nitrate (KN03') was assimilated and that sucrose was not assimilated, in agreement with the findings of Scholer et al. (8) . In addition, glucose was assimilated but lactose was not.
The first reported case of zygomycosis caused by M. ramosissimus occurred in a 39-year-old Caucasian woman with no obvious underlying disease who developed chronic destructive mucocutaneous disease lasting 24 years (10) . The second case discussed in the literature involved a 39-yearold, alcohol-abusing, diabetic black male who developed rhinocerebral disease (1) . Both cases, as well as the case we studied, subsequently responded to amphotericin B therapy; the first patient also required surgery. Hesseltine and Ellis provided a detailed description of the fungus in the first case and designated it the neotype strain (3). They concluded that this isolate represented a species described as a saprophyte many years ago in Russia (7) . No description was provided for the second isolate (1) .
In general, our isolate resembles that described by Hes- The microbiologist should consider M. ramosissimus in the differential identification when the following are initially observed: (i) persistent (not breaking or diffluent), small, brownish sporangia lacking columellae; (ii) short, erect sporangiophores repeatedly branched sympodially (Fig. 2) ; (iii) numerous chains of oidia (arthrospores); and (iv) optimum growth at 30°C, restricted growth at 36 to 37°C, and no growth at 40°C. A tentative identification may be reached by (i) thoroughly searching 7-day-old teased mounts for columellae (if necessary, tapping the preparation to dislodge or break up the larger sporangia and uncover the columellae) and (ii) preparing butt (deep) cultures in PDA and observing them for low grayish colonies after incubation for 7 days at 23°C (Fig. 1) 
